These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14670969)

  • 1. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death.
    Milakovic T; Tucholski J; McCoy E; Johnson GV
    J Biol Chem; 2004 Mar; 279(10):8715-22. PubMed ID: 14670969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
    Tucholski J; Johnson GV
    J Neurochem; 2002 May; 81(4):780-91. PubMed ID: 12065637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation.
    Tucholski J; Johnson GV
    J Biol Chem; 2003 Jul; 278(29):26838-43. PubMed ID: 12743114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation.
    Fabbi M; Marimpietri D; Martini S; Brancolini C; Amoresano A; Scaloni A; Bargellesi A; Cosulich E
    Cell Death Differ; 1999 Oct; 6(10):992-1001. PubMed ID: 10556977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
    Zhang J; Lesort M; Guttmann RP; Johnson GV
    J Biol Chem; 1998 Jan; 273(4):2288-95. PubMed ID: 9442073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.
    Piacentini M; Farrace MG; Piredda L; Matarrese P; Ciccosanti F; Falasca L; Rodolfo C; Giammarioli AM; Verderio E; Griffin M; Malorni W
    J Neurochem; 2002 Jun; 81(5):1061-72. PubMed ID: 12065619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for high and low molecular weight tissue transglutaminases in transforming mammalian cell properties.
    Mezzogiorno A; Esposito V
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):223-32. PubMed ID: 12477288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
    Boehm JE; Singh U; Combs C; Antonyak MA; Cerione RA
    J Biol Chem; 2002 Jun; 277(23):20127-30. PubMed ID: 11956182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein.
    Mishra S; Melino G; Murphy LJ
    J Biol Chem; 2007 Jun; 282(25):18108-18115. PubMed ID: 17478427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.
    Melino G; Annicchiarico-Petruzzelli M; Piredda L; Candi E; Gentile V; Davies PJ; Piacentini M
    Mol Cell Biol; 1994 Oct; 14(10):6584-96. PubMed ID: 7935379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired mitochondrial function results in increased tissue transglutaminase activity in situ.
    Lesort M; Tucholski J; Zhang J; Johnson GV
    J Neurochem; 2000 Nov; 75(5):1951-61. PubMed ID: 11032884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological separation of the expression of tissue transglutaminase and apoptosis after chemotherapeutic treatment of HepG2 cells.
    Uray IP; Davies PJ; Fésüs L
    Mol Pharmacol; 2001 Jun; 59(6):1388-94. PubMed ID: 11353797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R; Inbal A
    Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tissue transglutaminase antibody inhibits apoptotic cell clearance by macrophages in pregnant NOD mice.
    Sóñora C; Mourglia-Ettlin G; Calo G; Hauk V; Ramhorst R; Hernández A; Leirós CP
    J Reprod Immunol; 2014 Jun; 103():59-66. PubMed ID: 24377394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity.
    Nicholas B; Smethurst P; Verderio E; Jones R; Griffin M
    Biochem J; 2003 Apr; 371(Pt 2):413-22. PubMed ID: 12533191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
    Rossin F; D'Eletto M; Macdonald D; Farrace MG; Piacentini M
    Amino Acids; 2012 May; 42(5):1793-802. PubMed ID: 21479826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue transglutaminase in GTP depletion-induced apoptosis of insulin-secreting (HIT-T15) cells.
    Huo J; Metz SA; Li G
    Biochem Pharmacol; 2003 Jul; 66(2):213-23. PubMed ID: 12826264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
    Colak G; Keillor JW; Johnson GV
    PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase triggers oligomerization and activation of dual leucine zipper-bearing kinase in calphostin C-treated cells to facilitate apoptosis.
    Robitaille K; Daviau A; Tucholski J; Johnson GV; Rancourt C; Blouin R
    Cell Death Differ; 2004 May; 11(5):542-9. PubMed ID: 14739943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and activity of transglutaminase, a retinoid-inducible protein, in developing rat spinal cord.
    Perry MJ; Haynes LW
    Int J Dev Neurosci; 1993 Jun; 11(3):325-37. PubMed ID: 8102831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.